Form 8-K - Current report:
SEC Accession No. 0001104659-25-036841
Filing Date
2025-04-21
Accepted
2025-04-21 16:15:25
Documents
14
Period of Report
2025-04-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2512703d1_8k.htm   iXBRL 8-K 36775
2 EXHIBIT 10.1 tm2512703d1_ex10-1.htm EX-10.1 680726
  Complete submission text file 0001104659-25-036841.txt   1037752

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mnmd-20250418.xsd EX-101.SCH 3008
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnmd-20250418_lab.xml EX-101.LAB 34239
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnmd-20250418_pre.xml EX-101.PRE 22354
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2512703d1_8k_htm.xml XML 3791
Mailing Address ONE WORLD TRADE CENTER SUITE 8500 NEW YORK NY 10007
Business Address ONE WORLD TRADE CENTER SUITE 8500 NEW YORK NY 10007 212-220-6633
Mind Medicine (MindMed) Inc. (Filer) CIK: 0001813814 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40360 | Film No.: 25853336
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)